The Visionary's
Fast Track to Market

CEVR: Accelerating the Journey
from Translational Research to Commercialization

The InnoHK Centre for Eye and Vision Research (CEVR) stands at the global forefront of eye and vision research, powered by the prestigious academic heritage of The Hong Kong Polytechnic University (PolyU) and the University of Waterloo (UWaterloo) in Canada.

Backed by the HKSAR Government, the Hong Kong Science Park (HKSTP), and industrial leaders, CEVR thrives within a robust 360-degree support ecosystem. This strategic foundation provides us with secure funding, and state-of-the-art facilities, fostering a seamless, cross-border synergy that accelerates the R&D lifecycle.

By merging world-class scientific pedigree with industry-driven innovation, CEVR serves as a high-velocity conduit for translating breakthrough discoveries into real-world healthcare solutions. A partnership with CEVR is more than an entry point; it is a dedicated fast track for commercialization. We bridge the gap between clinical insight and market application, giving our partners a decisive edge in bringing life-changing visual technologies to the global stage.

World-Class Intellectual Capital

Global Talent
Leverage a multidisciplinary team of over 100 world-class professionals and internationally recognized researchers drawn from optometry, vision science, pharmacy, biology, chemistry, and applied technology.
Institutional Leadership
Leverage the collective academic excellence, pioneering methodologies, and innovative spirit of two world-leading universities renowned for their breakthroughs in eye and vision research.

Strategic Market Access

Strategic Regional Gateway
Leverage our premier base in the Hong Kong Science Park (HKSTP) as a high-velocity launchpad into the Hong Kong and global market.
Mainland Connectivity
Gain exclusive commercial pathways into Mainland China. Through CEVR's strategic partnerships with industry leaders in Mainland China, we bridge the gap between breakthrough research and large-scale clinical application.
A Global I&T Hub
Positioned at the heart of the Greater Bay Area, Hong Kong combines a robust legal framework and government-backed incentives with a world-leading academic ecosystem to accelerate the journey from lab to market.

Accelerated Technological Advancement

IP Portfolio
Commercialize innovations backed by a wide-spectrum and growing patent portfolio.
Technical Mastery
Address complex technical challenges with CEVR's deep scientific expertise, reinforced by industry partnerships.
R&D Acceleration
Benefit from focused translational R&D strategy which drives the commercialization outcomes much faster.

Advanced R&D Infrastructure

Advanced Facilities
Conduct R&D within advanced bioscience laboratories by leveraging the world-class infrastructure of the Hong Kong Science Park and the prestigious, government backed InnoHK initiative.
Clinical Rigor & Compliance
Maintain a gold standard of research through meticulous adherence to international regulatory frameworks and high-quality clinical validation.
Rapid Commercialization
With the support of experienced executives at CEVR, research outcomes can be translated into commercial applications more efficiently, accelerating impact in areas such as myopia, traditional Chinese medicine, and dry eye disease.

As an official Designated Local Research Institution (DLRI), CEVR serves as a strategic pillar in Hong Kong's mission to become a global innovation hub. This elite status transforms your R&D investment into a powerful financial catalyst through the Enhanced Tax Deduction scheme. By leveraging this government-vetted framework, our partners significantly maximize fiscal efficiency, turning research expenditure into a decisive competitive advantage while accelerating the path to market.

LEARN MORE